Research
Loma Linda University awarded more than $2 million grant by state of California to address adverse childhood experiences
Precision medicine project addresses ACEs in Inland Empire through multi-component interventions
Research
Study: Demographic factors associated with poorer outcomes in cancer patients who contract COVID-19
LLU Cancer Center physicians contributed, analyzed cases from the largest registry for cancer patients with COVID-19
Research
Partnership with Black churches increases COVID-19 vaccine delivery among historically at-risk population
New approach uses mobile vaccine clinics in church parking lots of Black communities
Research
Family-level traumatic experiences linked to biological indicators of health outcomes in children
Study explored association between adverse childhood experiences and biomarkers
Research
Study identifies two genes contributing to Hispanic, Latino children with leukemia faring worse than other groups
LLU researchers’ findings grant insight into major health disparity; could improve prognosis, treatments for minority groups
Research
Novel care pathway for maternal hypertension expedites treatment, can reduce disparities
Framework uses scalable, nurse-led treatment algorithm to reduce maternal complications
Research
Loma Linda University Health announces study of combination monoclonal antibody treatment for early COVID-19
ACTIV-2 is studying multiple early COVID-19 treatments
Research
McCarthy Family Foundation gives $1 million donation to Neuropathic Therapy Center to Expand Neuropathy Research
Donation used in part to expand carpal tunnel research, will use additional funds to promote research in other areas of medicine
Research
New research further links eating walnuts with lowered risk of heart disease
Study finds benefits on six anti-inflammatory biomarkers in older adults
Research
Loma Linda University Health participating in national COVID-19 study at Harvard
Research is examining treatments and affected populations